Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Biolex seeks approvals for phase I trials of BLX-883

Jan. 13, 2005

Scientists at Enanta report novel agents for hepatitis C infections

Jan. 12, 2005

HCV NS3-NS4A protease inhibitor and INF-alpha synergistically inhibit HCV replication in vitro

Jan. 12, 2005

IND submission for HCV-796

Jan. 12, 2005

Approvable letter for Sanvar IR for esophageal variceal bleeding

Jan. 10, 2005

Bristol-Myers Squibb patent covers new agents for hepatitis C infection

Jan. 10, 2005

IND filing for clinical testing of Probactrix for pouchitis

Jan. 10, 2005

Enrollment under way in phase I study of TD-2749 for GI motility dysfunction

Jan. 5, 2005

Pfizer claims compounds with dual 5-HT4 agonist/5-HT3 antagonist activity for GI disorders

Jan. 5, 2005

Zadaxin triple combination therapy tested in new European phase III trial

Dec. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...